Lion TCR Stock
Lion TCR is a clinical-stage biotechnology company.
Sign up today and learn more about Lion TCR Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Lion TCR Stock
They are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia. For the past decade, they have accumulated expertise covering the entire product development process, ranging from basic research, T cell engineering and development, and preclinical/clinical assessment. Led by industry and academic experts from their base in Singapore, they are dedicated to the commercialization and continued development of their immunotherapy products.
Co-Founder, Chairman & CEO